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Abstract
Objective
To report 6 new patients with cerebral dysgenesis, neuropathy, ichthyosis, and keratoderma
(CEDNIK) syndrome.
Methods
Clinical exome or targeted sequencing were performed to elucidate the molecular genetic cause
in patients with neurocognitive abnormalities and brain imaging ﬁndings.
Results
CEDNIK syndrome is a rare genetic condition caused by biallelic pathogenic loss-of-function
variants in synaptosomal-associated protein 29 (SNAP29), which encodes a vesicular membrane fusion protein. Clinical manifestations include signiﬁcant developmental delay/
intellectual disability (DD/ID), brain abnormalities, failure to thrive, and skin abnormalities.
To date, 19 patients from 10 unrelated families with CEDNIK syndrome have been reported.
We report 5 additional patients with homozygous predicted loss-of-function variants in
SNAP29 and one with compound heterozygous variants: a frameshift SNAP29 variant and a
370 kb deletion on 22q11.2. All patients exhibit DD/ID, ichthyosis and/or palmoplantar
keratoderma, and hypotonia. Four of 6 subjects had hypomyelinated white matter on MRI, 2 of
6 had early puberty, and 4 of 6 had strabismus, which were previously rarely reported. Other
phenotypes were variably present, including dysmorphic features, feeding diﬃculties, and recurrent respiratory infections. The cohort includes 2 siblings with a c.2T>C variant who have a
relatively milder phenotype, a patient with the most C-terminal variant yet described
(c.622G>T), and 3 patients with previously described variants (c.354dupG, c.487dupA).
Conclusions
This cohort of 6 additional patients expands the genotypic and phenotypic spectrum of
CEDNIK syndrome, highlighting previously under-recognized features such as hypomyelination, seizures, and early puberty. Owing to reduced penetrance of the skin phenotype, cerebral
dysgenesis, and neuropathy, we propose renaming this syndrome SNAP29-related disorder.
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Glossary
CMA = chromosomal microarray analysis; DD = developmental delay; ID = intellectual disability; NMD = nonsense-mediated
mRNA decay; OFC = occipitofrontal circumference; PMG = polymicrogyria; PMLD = Pelizaeus-Merzbacher-like disorder;
SNAP29 = synaptosomal-associated protein 29.

Cerebral dysgenesis, neuropathy, ichthyosis, and keratoderma
(CEDNIK) syndrome (MIM# 609528) was ﬁrst described by
Sprecher et al.1 in 2005, and to date, 19 individuals from 10
unrelated families have been described.2–9 This is a rare autosomal recessive disease caused by loss-of-function variants
in synaptosomal-associated protein 29 (SNAP29). SNAP29 is
involved in membrane fusion processes including exocytosis,
endocytosis, autophagy, and ciliogenesis. In human skin and
animal models, loss of SNAP29 leads to abnormal maturation,
spatial organization, and diﬀerentiation of epidermal layers,
neurons, and muscle ﬁbers.1,10–13
CEDNIK syndrome is characterized by severe neurologic abnormalities leading to global developmental delay, hypotonia, and
neuropathy as well as dermatologic abnormalities (ichthyosis and
keratoderma). Typical MRI ﬁndings are hypoplasia/dysplasia of
the corpus callosum and polymicrogyria (PMG). Congenital
hypotonia leads to feeding diﬃculties, failure to thrive, and development of limb spasticity. Individuals with CEDNIK syndrome meet few developmental milestones and often have vision
or hearing loss. Most patients have dysmorphic facial features
without a recognizable gestalt. Prognosis is poor; the eldest patient was 13 year old at publication, and 4 patients died of
pneumonia between ages 5 and 12.1,8
Here, we describe 6 additional patients with CEDNIK syndrome from 5 unrelated families, one of whom is older than
any previous patient described. Their genotypes include a
novel C-terminal predicted pathogenic variant in SNAP29 and
a variant previously associated with Pelizaeus-Merzbacher-like
disorder (PMLD).7

Methods
Standard Protocol Approvals, Registrations,
and Patient Consents
Written informed consent and authorization for publication
was received from patients’ guardians. The Washington
University in St. Louis Media Authorization for the Use and
Disclosure of Protected Health Information form was used for
all patients except patient 4, who used the Kingston General
Hospital Consent for Photography form.
Genetic Testing
Next-generation sequencing was performed at each institution on a clinical basis for evaluation of speciﬁc ﬁndings
(see also Supplementary Material-B). For patients 1 and 4,
trio exome sequencing was performed through GeneDx
(Gaithersburg, MD). Patient 2 had targeted testing (GeneDx)
2
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for the familial pathogenic variant previously found in his
sister. For patient 3, a chromosomal microarray analysis
(CMA) was performed at Children’s Hospital Los Angeles.
An XomeDxSlice (GeneDx) was performed to sequence
candidate genes SNAP29 and PEX7. Patient 5 had a CMA,
followed by exome sequencing by Genome Diagnostics
(Nijmegen, The Netherlands). Patient 6 had exome sequencing by Mendelics (Sao Paolo, Brazil).
Clinical History
Clinical history was obtained from chart review and/or discussion with the patient’s parents. Growth and occipitofrontal
circumference (OFC) percentiles refer to World Health Organization charts for ≤2 years of age and Centers for Disease
Control Prevention charts for >2 years.
Statistics
“N-1” χ 2 test with 2-tailed p value (medcalc.org) was used to
compare proportions between groups.
Data Availability
Anonymized data will be shared by request from any qualiﬁed
investigator.

Results
Molecular Results
Table 1 and ﬁgure 1A diagram shows the SNAP29 variants in
the 6 patients in this cohort compared with previously
reported cases.
Patients 1 and 2 are homozygous for a c.2T>C variant in
SNAP29. This is predicted to alter the initiation codon with
uncertain protein product (p.Met1?) and was previously
reported as a compound heterozygous variant in a patient
with PMLD.7
Patient 3 has a region of homozygosity detected by CMA at
chromosome 22q11.2 encompassing 32 OMIM genes. Targeted testing revealed a homozygous frameshift pathogenic
variant (c.354dupG; p.Leu119Alafs*15) in SNAP29, which
was previously associated with CEDNIK syndrome.6
Patient 4 has a homozygous c.622G>T; p.Glu208* nonsense
variant in the last exon of SNAP29. This variant is the most
C-terminal yet described. In addition, CMA showed a 1.22
Mb duplication of unclear clinical signiﬁcance at 8p23.2
containing CSMD1, deletions of which have been associated
with head and neck cancers.14
Neurology.org/NG

Table 1 SNAP29 Mutations Described to Date
Ref.

N

Ethnicity

SNAP29 variant

Predicted protein change

1

6 sibs

Arab

c.223delG

p.Val75Serfs*28

1

Arab

c.223delG

p.Val75Serfs*28

2

2 sibs

Kashmiri Pakistani

c.487dupA

p.Ser163Lysfs*6

3

2 sibs

Jordanian

c.223delG

p.Val75Serfs*28

4

1

Jordanian

c.85C>T

p.Arg29*

5

1

Indian

c.253C>T

p.Arg85*

6

1

N/A

c.354dupG

p.Leu119Alafs*15

7

1

Caucasian, Hispanic

c.2T>C, c.354dupG

p.Met1?; p.Leu119Alafs*15

8, 9

3 sibs

Pakistani

c.487dupA

p.Ser163Lysfs*6

1

Pakistani

c.487dupA

p.Ser163Lysfs*6

1

N/A

c.388insGA, D22q11.2

p.Thr130Argfs*17

1

N/A

c.28delCCGTT, D22q11.2

p.Pro10Argfs*42

1

N/A

c.265G>A, D22q11.2

p.Glu89Lys

1

N/A

c.268C>T, D22q11.2

p.Arg90Cys

2 sibs (Pts 1, 2)

Amish, Mennonite

c.2T>C

p.Met1?

1 (Pt 3)

Hispanic Mexican

c.354dupG

p.Leu119Alafs*15

1 (Pt 4)

Tibetan, Indian

c.622G>T

p.Glu208*

1 (Pt 5)

Arab

c.487dupA

p.Ser163Lysfs*6

1 (Pt 6)

Brazilian

c.354dupG, 370kb deletion

p.Leu119Alafs*15

16

This paper

Notation per Human Genome Structural Variation Consortium 2016 guidelines.
* Indicates stop codon, fs*# indicates frame shift producing # mutated amino acids (including the stop codon), ? indicates unknown product, Δ indicates
microdeletion leading to 22q11.2 deletion syndrome. Patients are homozygous for variant listed unless 2 variants listed. Please note that Sprecher et al.1 refer
to c.223delG in their publication as c.220delG as they started numbering after the initiation codon.

Patient 5 has a homozygous, previously described pathogenic
frameshift variant in SNAP29 designated c.487dupA;
p.Ser163Lysfs*6. Cell culture experiments suggest that the
mutated protein is produced at normal levels with abnormal
localization.2
Patient 6’s exome sequencing revealed a heterozygous
c.354dupG; pLeu119Alafs*15 mutation in SNAP29 and an
approximately 370 kb deletion in 22q11.2 encompassing 4
OMIM genes (SNAP29, PI4KA, SERPIND1, and LZTR1).
Biallelic PI4KA variants in 3 unborn fetuses were associated
with PMG, cerebellar hypoplasia, and arthrogryposis (MIM
#616531),15 but no variants in PI4KA were detected in patient 6.
Case Reports
Patient 1

Patient 1 is a 19-year-old woman of mixed Amish and Mennonite heritage whose parents estimate they are ﬁfth cousins
(ﬁgure 1B). Pregnancy was complicated by maternal malarial
Neurology.org/NG

infection, but she was born at full-term without signiﬁcant
complications.
Patient 1 had no signiﬁcant health problems in her ﬁrst year of
life. She was late to walk (24 months) and talk (2–3 years).
She developed seizures at the age of 4; EEG showed multifocal epileptiform discharges. Repeat EEG at the age of 8
showed discharges in the left occipital and bilateral temporal
regions. Seizures stopped on antiepileptic medication by the
age of 10. She had premature thelarche with breast development at the age of 7, but menstruation began at the age
of 9. She lost motor and speech milestones at the age of
12–13. She uses a wheelchair but walks with assistance. She
knows few words, and her speech is dysarthric. She is hyperopic and required 3 corrective surgeries for strabismus. She
exhibits constipation.
On physical examination at the age of 18, her height, weight,
and OFC were <1st, 22nd, and 40th percentile, respectively.
She has mild hypotelorism, a round face, and slightly deepset eyes (ﬁgure 2A). Dermatologic ﬁndings include mild
Neurology: Genetics | Volume 7, Number 1 | February 2021
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Figure 1 Mutation Map of SNAP29 Variants and CEDNIK Case Report Pedigrees

(A) SNAP29 variants shown by cDNA position and
nucleotide change with notations per Human
Genome Structural Variation Consortium 2016
guidelines. Listed next to each variant are associated cases, noted as labelled gray circles. Labels
#1–6 (light gray) indicate patients reported in this
manuscript. Lettered labels indicate cases
reported by previous reports (dark gray), noted
by the first author’s last initial. Please note, all
patients carry homozygous variants except L1
(compound heterozygous),7 M1-4 (hemizygous,
gray arrows),16 and patient 6 (hemizygous). (B)
Patient pedigrees. Symbol key: =consanguineous
marriage, circle: female, square: male, triangle:
miscarriage, filled: affected (numbers refer to
subjects in this cohort), half-filled: known
asymptomatic carrier. Note both miscarriages
were first trimester and did not undergo genetic
testing. cDNA = complementary DNA; CEDNIK =
cerebral dysgenesis, neuropathy, ichthyosis, and
keratoderma; SNAP29 = synaptosomal-associated protein 29.

ichthyosis on her limbs and palmoplantar keratoderma
(ﬁgure 2B). Examination revealed truncal hypotonia, lower
extremity hypertonia/clonus with hamstring tightness, and
scoliosis.
Patient 2

Patient 2 is a 13-year-old boy and the youngest sibling of
patient 1 (ﬁgure 1B). He was delivered at term after an uncomplicated pregnancy and required oxygen supplementation
for 2 hours for respiratory distress.
Patient 2 had no signiﬁcant health problems as an infant. He
had a seizure at the age of 3 but did not require antiepileptics
and had a normal EEG. His DD is less severe than patient 1’s;
he sat without support and crawled at 7 mo, walked at 18 mo,
and can run, jump, and ride a bike with training wheels. He
can trace words, count to 13, and speaks in short sentences
with some dysarthria and a signiﬁcant stutter. He had one
surgery for strabismus and wears glasses for hyperopia. His
pubertal development has been normal.
On physical examination at the age of 12, patient 2’s height,
weight, and OFC were normal. His facial features are similar
4
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to his sister’s, with more severe dermatological involvement
including wide-spread ichthyosis and keratoderma of his soles
(ﬁgure e-1, links.lww.com/NXG/A366). Examination
showed truncal hypotonia, lower extremity hypertonia with
tight hamstrings, hyperreﬂexia, and a dragging wide-based
gait.
Patient 3

Patient 3 is a 9-year-old girl of Hispanic Mexican descent
whose parents estimate they are second cousins. The proband
was the mother’s ﬁfth pregnancy; her 4 older brothers are
healthy, although one has ADHD (ﬁgure 1B).
At birth, patient 3 had diﬃculty feeding and received a G-tube
at the age of 2 for failure to thrive. She was diagnosed with
cerebral palsy with spastic diplegia. Breast development
started at the age of 8 (early normal). She has global DD; at 9
years, she can sit, crawl, walk for 1 minute with assistance, and
speaks one 2-word phrase. She has been hospitalized for recurrent pneumonia and bronchiolitis. She received corrective
surgery for strabismus. She takes levothyroxine for hypothyroidism, gabapentin for spasticity, and laxatives for
constipation.
Neurology.org/NG

Figure 2 Representative Facial Features and Skin Findings in Patients With CEDNIK

There was no recognizable gestalt of features among the patients described in this study. Patient 1 (age 18) displays (A) mild hypotelorism and (B)
keratoderma of the soles of the feet. Patient 5 (age 6) displays (C) short forehead with bitemporal narrowing, low-set ears, microphthalmia, high-arched
palate. Epicanthal folds, strabismus, anteverted nares, a short philtrum with bowed upper lip, micrognathia, a high-arched palate, and (D) generalized
ichthyosis, here shown on the back. CEDNIK = cerebral dysgenesis, neuropathy, ichthyosis, and keratoderma.

On physical examination at the age of 7, her height and weight
were <1st and 11th percentile, respectively. She is microcephalic
with bitemporal narrowing and has thick eyebrows, epicanthal
folds, and ﬂaring nares with a bulbous nasal tip. Her skin examination showed diﬀuse ichthyosis that peels extensively every few
days and palmoplantar keratoderma (ﬁgure e-1, links.lww.com/
NXG/A366). She is nonverbal and exhibits repetitive behaviors,
purposeless movements, and roving eye movements. Ophthalmologic examination showed nystagmus and foveal hypoplasia.
Neurologic examination showed increased muscle tone in the
lower extremities and bilateral sensorineural deafness.
Patient 4

Patient 4 is a 4-year-old girl of Tibetan & Indian descent. Her
parents have no known consanguinity. She was the second of
3 pregnancies and delivered at full term; her siblings are
healthy (ﬁgure 1B).
At 18 months, patient 4 required a G-tube for feeding diﬃculties and poor weight gain. She has global DD complicated
by cortical visual impairment and profound sensorineural
deafness. At the age of 4, she can form a pincer grasp but is
unable to walk because of profound hypotonia. She does not
speak. She had multiple admissions for aspiration pneumonia.
She takes omeprazole for gastroesophageal reﬂux, domperidone for gastrointestinal dysmotility, and salbutamol and
ﬂuticasone propionate for asthma.
On physical examination at the age of 3, height, weight, and
OFC were 3–10th, 10th, and 50th percentile, respectively.
Dysmorphic features include plagiocephaly, right-hand single
palmar crease, and thinning hair at the temporal regions. Skin
examination showed ichthyosis without keratoderma (ﬁgure
e-1, links.lww.com/NXG/A366). Ophthalmologic examination showed hyperopia, nystagmus, and strabismus.
Neurology.org/NG

Patient 5

Patient 5 is a 7-year-old boy of Arabian descent whose parents
are third cousins (ﬁgure 1B). He was born at term after an
uncomplicated pregnancy and noted to have craniofacial
dysmorphism, hypotonia, and nystagmus at birth.
During infancy, patient 5 had feeding diﬃculties, gastroesophageal reﬂux, failure to thrive, and recurrent respiratory
tract infections leading to multiple hospitalizations. He also
had a 1 mm patent foramen ovale that resolved. He developed
seizures at 4 months with multifocal epileptiform discharges
on EEG, for which he took phenobarbitone until seizures
resolved at the age of 2. At 2.5 years old, he was <2nd percentile for OFC and weight (from 12th and 34th at birth). He
sat with support at the age of 3 and stood with support at the
age of 3.5, but at the age of 7, he no longer stands independently. He holds a spoon but cannot feed himself. His
ﬁrst word was at 2.5 years old, and his vocabulary is restricted
to 2 words.
On physical examination at the age of 6.5, height, weight,
and OFC were <2nd, 5th, and 2nd percentile, respectively.
Patient 5 has microcephaly with a short forehead and
bitemporal narrowing, low-set ears, microphthalmia, epicanthal folds, anteverted nares, a short philtrum with
bowed upper lip, micrognathia, and a high-arched palate
(ﬁgure 2C). Examination also showed hypotonia, scoliosis, and generalized ichthyosis without palmoplantar keratoderma (ﬁgure 2D). Ophthalmologic examination
showed horizontal nystagmus, convergent strabismus, and
myopia.
Patient 6

Patient 6 is a 2-year-old Brazilian boy whose parents are second
cousins (ﬁgure 1B). He was born at term after an uncomplicated
Neurology: Genetics | Volume 7, Number 1 | February 2021
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Figure 3 Brain MRI of Patient 1 Shows Corpus Callosum
Dysgenesis and Loss of Supratentorial Myelin

He eats well but has diﬃculty gaining weight. He has global
DD; at the age of 2, he sits with support but cannot walk and
babbles without producing words. He has signiﬁcant hearing
loss and right optic nerve hypoplasia. He takes laxatives for
constipation and melatonin for diﬃculty sleeping.
At the age of 2, height, weight, and OFC were <2nd, 10th, and
;70th percentile, respectively. He has mildly dysmorphic
features with synophrys, bushy eyebrows, epicanthal folds,
and a broad, depressed nasal bridge. Skin ﬁndings include
ichthyosis and plantar keratoderma (ﬁgure e-1, links.lww.
com/NXG/A366). He has truncal hypotonia, poor limb
movement, and tight Achilles tendons.
Radiologic Findings
Typical radiographic ﬁndings of CEDNIK syndrome are dysgenesis of the corpus callosum and PMG. Corpus callosum
dysgenesis was seen in the brain MRIs of all patients except
patient 3 (ﬁgures 3, e-3, e-4, e-5, links.lww.com/NXG/A366).
Patient 3’s MRI was read as bilateral PMG, stable from 18 months
to 8 years of age (data not shown), and patient 4 has possible
PMG at the Sylvian ﬁssures (ﬁgure e-4); patient 5’s MRIs at 4
days and 10 months of age were initially reported as lissencephaly
with PMG and mild cerebellar hypoplasia, although this ﬁnding
was not clear on reread at another institution (ﬁgure 4). However,
imaging of patients 1, 2, and 6 did not show evidence of PMG.

(A) T1-weighted MRI showing normal myelination at 14 months but loss of
normal T1 hyperintense white matter signal at 12 years consistent with
severe hypomyelination (yellow arrows). (B) T1-weighted MRI showing
dysgenesis of the corpus callosum with a deficient splenium. Although there
is normal myelin in the genu of the corpus callosum at 14 months, it is lost at
12 years (orange arrows). In addition, there is platybasia with resultant
kinking of the medulla oblongata. (C) Single voxel proton MR spectroscopy
with TE 144 ms at 12 years of age. Top row: T1W, T2 FLAIR, and T2W images
show abnormal white matter. Bottom row: spectrum shows elevated choline relative to n-acetylaspartate (NAA) in the right frontal lobe white matter,
consistent with the loss of sphingolipid in the myelin and suggestive of
myelin breakdown. A normal spectrum should show reversed levels of NAA
and choline.17.

pregnancy and was noted to have shortened Achilles tendons. He
required a 1-month NICU stay for fever, hypoglycemia, and
thrombophilia, possibly related to SERPIND1/heparin cofactor II
deﬁciency (see Molecular Results).16
6
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The most striking and under-recognized ﬁnding in this cohort
of patients was white matter T1 hypointensity/T2 hyperintensity consistent with decreased sphingolipid in the myelin
sheath, characteristic of white matter disease. Patient 1 had
serial MRIs showing fairly normal supratentorial white matter
at 14 months of age but a striking lack of supratentorial myelin
signal by age 12 years (ﬁgure 3, e-2, links.lww.com/NXG/
A366). MR spectroscopy showed increased choline relative to
n-acetylaspartate, consistent with metabolic breakdown of the
myelin sheath.17 MRIs from patient 2 (age 3, ﬁgure e-3),
patient 4 (age 2, ﬁgure e-4), and patient 6 (7 months, data not
shown) also suggest decreased supratentorial myelin content.
Although less severe, patient 5 had subtle hypomyelination in
the occipital region at 10 months (ﬁgure 4). Loss of white
matter, especially in the occipital areas, may have led to enlargement of the occipital horns of the lateral ventricles in
patients 2 (ﬁgure e-3), 5 (ﬁgure e-5), and 6 (data not shown).
We also describe several structural abnormalities that were
not previously associated with CEDNIK syndrome. Four
patients had an abnormal craniocervical junction with narrowing of the foramen magnum, represented by imaging from
patient 1 showing platybasia with kinking of the medulla
oblongata (ﬁgure 3), but also present in patients 2, 4, and 5.
Representative imaging from patient 5 (ﬁgure 4) shows abnormalities in the Sylvian ﬁssure that were also present in
patients 2 and 4, and T2 hyperintensity of the globus pallidi
shared with patient 4. T2 hyperintensity of the basal ganglia is
often linked to hypoxic, toxic, and/or metabolic insult, but its
underlying cause in CEDNIK syndrome is unclear.
Neurology.org/NG

Figure 4 Brain MRI of Patient 5 Shows Small Frontal Lobes,
Abnormal Sylvian Fissures, and T2 Hyperintensity
of the Globus Pallidus

(4/6 vs 3/16) (p = 0.0291), and constipation (3/6 vs 0/19) (p
= 0.0013) than previously reported (table 2). Although increased reporting of ﬁndings such as constipation and strabismus may be associated with changes in diagnosis since earlier
publications, other associations expand our understanding of
the disease phenotypes caused by SNAP29 variants.
These patients have widened the genotypic and phenotypic
spectrum of CEDNIK syndrome in several ways. First, 2 patients had early puberty, which was only reported in a single
previous case of CEDNIK syndrome.4 SNAP29 may play an
undiscovered role in sex hormone production because the
highest expression of SNAP29 is in the testes, and the expression in ovary is higher than all brain tissues analyzed.19
Given that many patients were prepubescent at time of publication, further investigation into the role of SNAP29 in endocrine regulation is required.

Axial T1W and T2W images at (A) 4 days of life and (B) at 10 month old.
Structural findings include small frontal lobes and abnormal Sylvian fissures
(orange arrows). Myelination in the newborn period is normal above the
tentorium because only the posterior limb of the internal capsule should be
myelinated.22 (B) At 10 months, there is subtle hypomyelination in the occipital regions, but some normal myelin is seen in the genu of the corpus
callosum. There is high T2W signal in the globus pallidus bilaterally (cyan
arrow).

Discussion
We describe 6 additional patients with CEDNIK syndrome
and review previously reported phenotypes and genotypes.
To date, 10 distinct variants in SNAP29 are associated with
disease in humans (table 1, ﬁgure 1A), including 4 heterozygous variants found in the context of 22q11.2 deletion
syndrome that were excluded from our phenotypic analysis.18
Patient 6 was included because his 370 kb deletion aﬀected
only 3 OMIM genes other than SNAP29, for which no variants were detected; however, we cannot completely exclude
contribution of these genes to his neurologic phenotype.
In the 19 patients with homozygous or compound heterozygous SNAP29 mutations reported earlier,1–9 no clear
genotype-phenotype correlation emerged (table 2). Compared with previous reports, patients in this report had a
higher occurrence of seizures (3/6 vs 7/19) (p = 0.5741),
strabismus (4/6 vs 2/19) (p = 0.0060), early puberty in pubescent patients (2/3 vs 1/2) (p = 0.7390), hypomyelination
Neurology.org/NG

Second, we report a 19-year-old patient who may be the
longest-surviving individual diagnosed with CEDNIK syndrome. Patients 1 and 2 are respectively the oldest patient and
most neurologically functional patient described so far. We
hypothesize that these unique features are because of lowlevel production of the c.2T>C; p.Met1? variant of SNAP29,
as transcripts with disrupted initiation codons can be translated using alternate start sites or alternate initiation codon
sequences.20 Evidence from one previously reported patient
showed mRNA from the c.2T>C allele was detectable in the
blood, but Western blotting of ﬁbroblasts did not detect
SNAP29 protein expression.7 It is unknown whether low
levels of SNAP29 not detectable by Western blot could be
mitigating the phenotypes of patients 1 and 2.
Third, we present a novel nonsense mutation in the ﬁnal exon,
c.622G>T (p.Glu208*), suggesting production of a truncated
protein. All previously reported frameshift and nonsense variants are predicted to cause loss of function through nonsensemediated mRNA decay (NMD). This truncated protein is likely
not functional, given the patient’s signiﬁcant disease burden,
with corpus callosum and white matter loss, profound hypotonia, blindness, deafness, and dysmorphic features. It is possible
that this variant has unique function, for example, interfering
with soluble N-ethylmaleimide-sensitive factor attachment
protein receptor (SNAP)/SNAP receptor (SNARE) complex
formation because of interruption of the C-SNARE domain.
Fourth, brain imaging of these patients identiﬁed several abnormalities not previously associated with CEDNIK syndrome. Four of 6 patients had white matter changes
consistent with signiﬁcantly decreased myelin content. Patient 1’s loss of myelin between age 14 months and 12 years of
age seems radiographically similar to Pelizaeus-Merzbacher
disease and could represent progressive hypomyelination.
Although the c.2T>C variant (carried by patients 1 and 2) was
described in a patient with hypomyelinating leukodystrophy
diagnosed with PMLD,7 the phenotype does not seem to be
exclusive to this variant because other patients (patients 4, 6,
Neurology: Genetics | Volume 7, Number 1 | February 2021

7

Table 2 Clinical Phenotypes Associated With CEDNIK Syndrome
Reference

(1)

(2)

(3)

(4)

(5)

(6)

(7)

(8),(9)

Pt 1

Pt 2

Pt
3

Pt
4

Pt 5

Pt 6

Total

Sex

3F,
4M

1F, 1M

2F

1M

1F

1M

1M

1F, 3M

F

M

F

F

M

M

11F, 14M

Age

5–13

11 mo,
4y

4
yc

10
y

20
mo

26
mo

12
y

2.5–12
y

19 y

13 y

9y

4y

7y

2y

11mo19y

Consanguinity

7/7

2/2

2/
2

1/
1

1/1

0/1

0/
1

4/4

Yes

Yes

Yes

No

Yes

Yes

22/25
(88%)

Feeding difficulty

7/7

2/2

2/
2

1/
1

1/1

1/1

0/
1

N/A

No

No

Yes

Yes

Yes

No

17/21
(81%)

GDD

7/7

2/2

2/
2

1/
1

1/1

1/1

1/
1a

4/4

Yes

Yesa

Yes

Yes

Yes

Yes

25/25
(100%)

Early puberty

N/A

N/A

N/
A

1/
1

N/A

N/A

0/
1

N/A

Yes

No

Yes

N/
A

N/A

N/A

3/5 (60%)

Respiratory
infections

3/7d

1/2

1/
2

1/
1

1/1

0/1

0/
1

1/4d

No

No

Yes

Yes

Yes

Yes

12/25
(48%)

Development

Neurologic and Brain MRI Findings
Corpus callosum
abnormality

4/4

2/2

2/
2

1/
1

1/1

1/1

1/
1

4/4

Yes

Yes

No

Yes

Yes

Yes

21/22
(95%)

Polymicrogyria

4/4

1/2

0/
2

1/
1

1/1

1/1

0/
1

4/4

No

No

Yes

No

Yesc

No

14/22
(64%)

Hypomyelination

0/4

0/2

0/
2

1/
1

1/1

0/1

1/
1

0/4

Yes

Yes

No

Yes

No

Yes

7/22
(32%)

Seizures

0/7

1/2c

0/
2

0/
1

0/1

1/1

0/
1

4/4

Yes

Yes

No

No

Yes

No

9/25
(36%)

Microcephaly

7/7

2/2

0/
2

0/
1

1/1

0/1

0/
1

1/4

No

No

Yes

No

Yes

No

13/25
(52%)

Truncal hypotonia

7/7

2/2

2/
2

1/
1

1/1

1/1

1/
1

4/4

Yes

Yes

Yes

Yes

Yes

Yes

25/25
(100%)

Limb spasticity

0/7

2/2

0/
2

1/
1

1/1

0/1

1/
1a

0/4

Yes

Yes

Yes

No

No

Yes

7/13
(54%)

Scoliosis

N/A

0/1

0/
2

1/
1

1/1a

0/1

0/
1

N/A

Yes

No

No

No

Yes

0/1

4/13
(31%)

Optic atrophy/
hypoplasia

7/7

N/A

2/
2

1/
1

0/1

N/A

1/
1a

4/4

No

No

No

No

No

Yes

16/22
(73%)

Roving eye
movements

7/7

1/2

0/
2

0/
1

1/1

0/1

0/
1

N/A

No

No

Yes

No

No

No

10/21
(48%)

Nystagmus

N/A

0/2

0/
2

0/
1

0/1

0/1

1/
1

N/A

No

No

No

Yes

Yes

No

3/14
(21%)

Strabismus

N/A

N/A

0/
2

1/
1

0/1

0/1

1/
1b

N/A

Yes

Yes

Yes

No

Yes

No

6/12
(50%)

Hearing loss

3/7a

2/2

0/
2

0/
1

1/1

0/1

0/
1

N/A

No

No

Yes

Yes

No

Yes

9/21
(43%)

Ichthyosis

7/7

2/2a

2/
2e

1/
1

1/1

1/1

0/
1

0/4

Yesa

Yes

Yes

Yes

Yes

Yes

20/25
(80%)

Keratoderma

7/7

2/2

2/
2

1/
1

1/1a

0/1

0/
1

0/4

Yes

Yes

Yes

No

No

Yes

17/25
(68%)

Musculoskeletal

Eye and ear

Dermatologic

Continued
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Table 2 Clinical Phenotypes Associated With CEDNIK Syndrome (continued)
(1)

(2)

(3)

(4)

(5)

(6)

(7)

(8),(9)

Pt 1

Pt 2

Pt
3

Pt
4

Pt 5

Pt 6

Total

Dysmorphic face

7/7

2/2

2/
2

1/
1

1/1

1/1

0/
1

0/4

No

No

Yes

Yes

Yes

Yesa

18/25
(72%)

Face shape

Elongated (8)1,2, round (2)Pt1,Pt2, short forehead w/bitemporal narrowing (1)Pt5, brachycephaly/triangular (2)3, plagiocephaly (1)Pt3

Eyes

Hypertelorism (10)1,5,Pt1,Pt2, deep-set (3)4,Pt1,Pt2, downslanting palpebral fissures (9)1,3, epicanthal folds (4)6,Pt3,Pt5,Pt6,
microphthalmia (1)Pt5

Ears

Large ears (1)4, low-set ears (2)5,Pt5, small ears with folded helix (2)3

Nose

Flat, broad root (11)1,3,5,Pt6, large/long (2)2,4, pointed tip (2)2, bulbous tip (1)Pt3, anteverted nares (1)Pt5, midface hypoplasia (1)6

Mouth

Small chin (1)2, short philtrum (1)Pt5, retrognathia (1)6, micrognathia + high-arched palate (4)2,3,Pt5, bifid uvula (1)4

Ectodermal

Sparse, brittle hair (2)2, thin hair at temples (1)Pt3, hirsuitism/low hairline (1)4, synophrys (3)4,5,Pt6, hypohidrosis (1)4, enamel
hypoplasia (1)5

Skeletal

Talipes equinovarus (1)2, knee contractures (1)2, coxa valga (1)4, camptodactyly (2)3, radial deviation of wrists (2)3, clinodactyly (2)4,5

Other

Small fontanelles (2)2, scarring alopecia(1)2, flat maxilla (1)3, colpocephaly (3)8, inverted nipples (1)2, single palmar crease (1)Pt3

Reference
Dysmorphic features

Denominator can be different from 25 based on availability of data.
“N/A” – clinical phenotype not assessed. Otherwise data were explicitly stated or inferred negative if not mentioned. Respiratory infections include recurrent
viral illness and pneumonia. Early puberty was not assessed for girls <8 and boys <9 year old. Hypomyelination includes leukodystrophy, white matter T2
hyperintensity, and white matter loss. Spasticity includes hyperreflexivity, hypertonia, and hamstring or Achilles tendon tightness; patients without spasticity
were hyporeflexive or flaccid. Spasticity and scoliosis were not assessed for infants <1 year old.
Dysmorphic features listed with (No. of patients affected)reference.
a
Mild or moderate phenotype.
b
Intermittent exotropia.
c
Uncertain.
d
Deaths from pneumonia/respiratory infection.
e
Collodion phenotype.

and 2 previously described cases of CEDNIK syndrome4,5) had
imaging evidence consistent with hypomyelination/white
matter loss. Thus, there is growing evidence that hypomyelination may be a feature of CEDNIK syndrome, supported by
data showing high SNAP29 expression in myelinating glial
cells.21 Serial imaging in future patients could help determine
which SNAP29 variants are associated with this pattern of white
matter disease. In addition, abnormal craniocervical junction
(C1-C2) anatomy in our patients led to narrowing of the foramen magnum and kinking of the medulla. Although patients
with both SNAP29 and TUBA8 variants had loss of the pontomedullary junction,8,9 our ﬁndings have not been previously
described in patients with CEDNIK syndrome and whether
they contribute to the disease phenotype is uncertain.
Finally, there are a growing number of patients in the literature
with SNAP29 pathogenic variants were not diagnosed with
CEDNIK syndrome because of the lack of ichthyosis or
keratoderma.7–9 In fact, keratoderma and ichthyosis were described in only 80% and 68% of cases, respectively (table 2). One
such patient who was compound heterozygous for c.2T>C and
c.354dupG variants in SNAP29 was diagnosed with PMLD.7
Although previous homozygous cases of c.2T>C and c.354dupG
had skin ﬁndings typical of CEDNIK syndrome, this compound
heterozygous patient did not, suggesting reduced penetrance of
dermatologic disease with SNAP29 loss-of-function. This is
supported by Snap29-deﬁcient mouse models, suggesting that
Neurology.org/NG

genetic or nongenetic modiﬁers aﬀect skin ﬁndings.13 The lack of
dermatologic ﬁndings in these patients can mislead clinicians who
may fail to test for SNAP29 variants. Furthermore, only a few of
the recently reported patients had PMG or neuropathy typical of
CEDNIK syndrome, although neuropathy has not been systematically evaluated. We believe that the skin ﬁndings, cerebral
dysgenesis, and neuropathy that were initially thought to be
cardinal features of this condition are not mandatory to establish a
disease diagnosis.
Given incomplete penetrance for ichthyosis, keratoderma,
neuropathy, and cerebral dysgenesis phenotypes in patients
with SNAP29 pathogenic variants (table 2), we propose the
nomenclature SNAP29-related disorder instead of CEDNIK
syndrome for all patients with deleterious SNAP29 variants
regardless of their phenotypic features.
We report 6 new patients with predicted loss-of-function variants
in SNAP29. All patients exhibit DD, ichthyosis and/or palmoplantar keratoderma, and hypotonia. We highlight previously
under-recognized features such as supratentorial hypomyelination, seizures, and early puberty. We also ﬁnd growing evidence
for reduced penetrance for the skin phenotype, cerebral dysgenesis, and neuropathy. Signiﬁcant phenotypic variability in
patients with SNAP29 variants suggests that CEDNIK syndrome
should be deﬁned genetically rather than as a speciﬁc constellation of neurologic, brain imaging, and skin ﬁndings.
Neurology: Genetics | Volume 7, Number 1 | February 2021

9

Acknowledgment
The authors thank the families of the patients described for
participating in this study. Thank you for being engaged,
dedicated, and curious.

References
1.

2.

Study Funding
A.Y.M. was supported by NIAID F30 AI129110.

3.

Disclosure
The authors report no disclosures. Go to Neurology.org/NG
for full disclosures.

4.

5.
6.

Publication History
Received by Neurology: Genetics May 22, 2020. Accepted in ﬁnal form
November 18, 2020.

7.

8.

9.

Appendix Authors
10.
Name

Location

Contribution

Annelise Y. MahSom, MD, PhD

Washington
University in St. Louis,
St. Louis, MO

Reviewed and
interpreted patient data
and drafted the
manuscript

Cristina Skrypnyk,
MD, PhD

Arabian Gulf
University, Bahrain

Collected patient data
and revised the
manuscript for
intellectual content

Andrea Guerin,
MD

Queen’s University
Kingston, Canada

Collected patient data
and revised the
manuscript for
intellectual content

11.

12.

13.

14.

15.

Raafat Hammad
Seroor Jadah,
MBBCh, AB Ped, SB
Ped

Bahrain Defense
Forces Royal Medical
Services Hospital,
Bahrain

Collected patient data
and revised the
manuscript for
intellectual content

Vinayak Nivrutti
Vardhan, MBBS,
DCH

Bahrain Defense
Forces Royal Medical
Services Hospital,
Bahrain

Collected patient data
and revised the
manuscript for
intellectual content

Robert C.
McKinstry, MD
PhD

Washington
University in St. Louis,
St. Louis, MO

Reviewed patient
imaging and revised the
manuscript for
intellectual content

19.

Conceptualized and
coordinated the study
and revised the
manuscript for
intellectual content

21.

16.

17.

Marwan S.
Shinawi, MD

10

Washington
University in St. Louis,
St. Louis, MO

Neurology: Genetics | Volume 7, Number 1 | February 2021

18.

20.

22.

Sprecher E, Ishida-Yamamoto A, Mizrahi-Koren M, et al. A mutation in SNAP29,
coding for a SNARE protein involved in intracellular traﬃcking, causes a novel
neurocutaneous syndrome characterized by cerebral dysgenesis, neuropathy, ichthyosis, and palmoplantar keratoderma. Am J Hum Genet 2005;77:242–251.
Fuchs-Telem D, Stewart H, Rapaport D, et al. CEDNIK syndrome results from lossof-function mutations in SNAP29. Br J Dermatol 2011;164:610–616.
Ben-Salem S, Nara S, Al-Shamsi AM, Valle D, Ali BR, Al-Gazali L. New Arab
family with cerebral dysgenesis, neuropathy, ichthyosis, and keratoderma
syndrome suggests a possible founder eﬀect for the c.223delG mutation.
J Dermatol 2015;42:821–822.
Hsu T, Coughlin CC, Monaghan KG, et al. CEDNIK: phenotypic and molecular
characterization of an additional patient and review of the literature. Child Neurol
Open 2017;4:2329048X17732314.
Poojary S, Shah KS, Bhalala KB, Hedge AU. CEDNIK syndrome in an Indian patient
with a novel mutation of the SNAP29. Pediatr Dermatol 2019;36:372–376.
Tiwana H, Raymond G, Kumar A. CEDNIK syndrome, a rare neuro-cutaneous
disorder. Neurology 2019;92:P1.6–050.
Llaci L, Ramsey K, Belnap N, et al. Compound heterozygous mutations in SNAP29 is
association with Pelizaeus-Merzbacher-like disorder (PMLD). Hum Genet 2019;138:
1409–1417.
Abdollahi MR, Morrison E, Sirey T, et al. Mutation of the variant alpha-tubulin
TUBA8 results in polymicrogyria with optic nerve hypoplasia. Am J Hum Genet
2009;85:737–744.
Diggle CP, Martinez-Garay I, Molnar Z, et al. A tubulin alpha 8 mouse knockout
model indicates a likely role in spermatogenesis but not in brain development. PLoS
One 2017;12:e0174264.
Schiller SA, Seebode C, Wieser GL, et al. Non-keratinocyte SNAP29 inﬂuences epidermal
diﬀerentiation and hair follicle formation in mice. Exp Dermatol 2016;25:647–649.
Pan PY, Cai Q, Lin L, Lu PH, Duan S, Sheng ZH. SNAP-29-mediated modulation of
synaptic transmission in cultured hippocampal neurons. J Biol Chem 2005;280:
25769–25779.
Mastodonato V, Beznoussenko G, Mironov A, Ferrari L, Deﬂorian G, Vaccari T.
A genetic model of CEDNIK syndrome in zebraﬁsh highlights the role of the
SNARE protein Snap29 in neuromotor and epidermal development. Sci Rep
2019;9:1211.
Keser V, Lachance JB, Alam SS, et al. Snap29 mutant mice recapitulate neurological
and ophthalmological abnormalities associated with CEDNIK syndrome. Commun
Biol 2019;2:375.
Toomes C, Jackson A, Maguire K, et al. The presence of multiple regions of homozygous deletion at the CSMDI locus in oral squamous cell carcinoma question the role
of CSMDI in head and neck carcinogenesis. Genes Chromosomes Cancer 2003;37:
132–140.
Pagnamenta AT, Howard MF, Wisniewski E, et al. Germline recessive mutatiosin
PI4KA are associated with perisylvian polymicrogyria, cerebellar hypoplasia, and
arthrogryposis. Hum Mol Genet 2015;24:3732–3741.
Heparin cofactor II; HCF2. In: Online Mendelian Inheritance in Man. Available at:
omim.org/entry/142360?search=serpind1&highlight=serpind1. Accessed April 19,
2020.
Zhang Y, Shi J, Wei H, Han V, Zhu WZ, Liu C. Neonate and Infant brain development
from birth to 2 years assessed using MRI-based quantitative susceptibility mapping.
Neuroimage 2019;185:349–360.
McDonald-McGinn DM, Fahiminiya S, Revil T, et al. Hemizygous mutations in
SNAP29 unmask autosomal recessive conditions and contribute to atypical ﬁndings in
patients with 22q11. 2DS. J Med Genet 2013;50:80–90.
GTEx portal: Gene expression for SNAP29 from GTEx analysis Release V8. The
broad Institute. Available at: gtexportal.org/home/gene/ENSG00000099940.
Accessed April 19, 2020.
Kearse MG, Wilusz JE. Non-AUG translation: a new start for protein synthesis in
eukaryotes. Genes Dev 2017;31:1717–1731.
Schardt A, Brinkmann BG, Mitkovski M, Sereda MW, Werner HB, Nave KA.
The SNARE protein SNAP-29 interacts with the GTPase Rab3a: Implications
for traﬃcking in myelinating glia. J Neurosci Res 2009;87:3465–3479.
Dubois J, Dehaene-Lambertz G, Kulikova S, Poupon C, Hüppi PS, Hertz-Pannier L.
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